Atlas Trials

Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia

Clinical trial NCT02473016 · COMPLETED

Trial details

NCT number
NCT02473016
Sponsor
Capnia, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Trigeminal Neuralgia
Start date
2015-09-01
Primary completion
2017-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.